Health Condition 1: J449- Chronic obstructive pulmonary disease, unspecified
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1.Patients between age 18- 75 years of age. 2.Patients having confirmed disease diagnosis according to the ICD11 list: CA22: Chronic Obstructive Pulmonary Disease 3.Period of Integrated-Pathy treatment greater than 1 month. 4.Informed consent to participate in the study and publish study-related data.
Exclusion criteria
Exclusion criteria: 1.Not willing to participate in the study/ no consent to publish data. 2.Incomplete pre/post-data questionnaires. 3.Patients with active pulmonary infections such as tuberculosis or pneumonia at the time of enrollment. 4.Period of Integrated-pathy treatment less than 1 month. 5.Inability to complete follow-up visits.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Improvement in Quality of Life (QoL) and symptomatic status among patients with Chronic Obstructive Pulmonary Disease (COPD)Timepoint: Quality of Life: Baseline (Day 0) and end of observation period/discharge (Day 28). Symptom Assessment: Baseline (Day 0) and end of observation period/discharge (Day 28). | — |
Secondary
| Measure | Time frame |
|---|---|
| 1.Prevalence of utilization of Integrated-pathy interventions among patients with COPD attending Patanjali Wellness. 2.Pattern of Integrated-pathy treatment modules utilized by COPD patients, including Ayurveda, Yoga, Naturopathy, dietary interventions, and lifestyle modification practices. 3.Comparison of treatment outcomes among COPD patients receiving different Integrated-pathy treatment approaches, based on changes in symptom scores and quality of life measures. 4.Patient-reported perception and satisfaction regarding Integrated-pathy interventions in the management of COPD. 5.Impact of Integrated-pathy on overall health status and functional well-being of COPD patients.Timepoint: 1.Prevalence of Integrated-pathy utilization: At enrollment. 2.Pattern of Integrated-pathy treatment modules: During the observation period. 3.Treatment outcome comparison: Baseline and end of observation period/discharge. 4.Patient satisfaction and perception: End of observation period/discharge. 5.Functional well-being assessment: Baseline and end of observation period/discharge. | — |
Countries
India
Contacts
University of Patanjali, Haridwar